In the eighties, Klaus studied veterinary medicine followed by a thesis in applied biochemistry in boar reproduction at the Veterinary School in Hannover, Germany.
From 1991 to 1994 Klaus worked at Pfizer Animal Health in Germany. Since 1995, Klaus is consulting the industry regarding animal health, the development and registration of animal health products and plans, supervises and conducts safety and efficacy studies testing veterinary medicinal products in various animal species. Since 1997, as founder, he is the CEO of the contract research organisation and regulatory consultancy KLIFOVET AG, Munich, Germany, one of the leading organisations providing dedicated services to support new product development and registration for animal health products. He has extensive experience consulting all, multinationals, family businesses and start-ups how to develop animal health products and has led various organisations to successful granting of marketing authorisations for vaccines, biologicals and pharmaceuticals.

Klaus is active in various animal health and veterinary organisations including the Association of Veterinary Consultants (AVC), the European College for Veterinary Pharmacology and Toxicology, member of AAVP, AAVPT and WAAVP and selected member of organisation committees of AAVM2014-2020 and acts regularly as organiser of international conferences.
Multiple scientific publications on antiparasitics, antimicrobials, vaccines, and novel therapies in various animal species show the broad spectrum of expertise (www.klifovet.com).